NCT04692883 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Cretnik A, Kosanovic M, Smrkolj V
Percutaneous suturing of the ruptured Achilles tendon under local anesthesia. J Foot Ankle Surg. 2004 Mar-Apr;43(2):72-81.
Cretnik A, Zlajpah L, Smrkolj V, Kosanovic M
The strength of percutaneous methods of repair of the Achilles tendon: a biomechanical study. Med Sci Sports Exerc. 2000 Jan;32(1):16-20.
Wong J, Barrass V, Maffulli N
Quantitative review of operative and nonoperative management of achilles tendon ruptures. Am J Sports Med. 2002 Jul-Aug;30(4):565-75. Review.

A Prospective Randomized Comparison of Functional Bracing Versus Rigid Immobilization After Modified Percutaneous Achilles Tendon Repair Under Local Anesthesia

Details for clinical trial NCT04692883

Clinical trial NCT04692883 - References